Here is the text of the presentation by an EC representative on the Three Diseases Fund. The presentation is attached.

********************************

The Three Diseases Fund
- A Collaborative Donor Effort
in response to a
Public Health Emergency -
The Three Diseases Fund
• Why?
• Who?
• How?
• What?
• When?
• How much?
Why?

– High burden of disease (HIV & AIDS, tuberculosis, malaria) throughout the country
– Working in Burma/Myanmar is possible (lessons learnt)
– Global Fund withdrawal August 2005: need for concerted donor response
– Overall objective:
        to reduce the burden of communicable     disease in Myanmar
Who?

– Six donors: AusAid, DfID, EC, Netherlands, Norway, Sida
– Fund Manager: UNOPS
– Fund Board: Donor reps + independent experts
– UN agencies, NGOs, CBOs, private sector, civilian administrations
How?

– Transparent allocation of resources through both competitive bidding and direct grants to support interventions within the framework of National Strategies (plus other priorities)
– Calls for expressions of interest, followed by detailed workplans and budgets
– Procurement by UNOPS and specialised agencies to ensure equitable access

What? (1)

Provision of services, technical assistance, quality medicines and commodities

Programme priorities: cross-cutting issues
• Access, Coverage, Capacity building, Strategic planning
• Equity, Participation, Gender, Accountability, Transparency
• Coordination, Integrated approaches

Policy development to be commissioned in areas of:
• Inclusion
• Gender
• Strategic Development
• Corruption

What? (2)
HIV & AIDS priority areas for support I
• Men and women who sell sex and their regular partners
• Men who pay for sex and their regular partners
• Men who engage in male-male sexual practices
• Intravenous drug users and their partners
• Those based in institutions
• Those vulnerable to infection as a result of mobility
What? (3)
HIV & AIDS priority areas for support II

• Targeted service provision focusing on those engaging in high risk practices and/or through routine SRH services

• Voluntary counselling and testing
• Prevention of mother to child transmission
• Diagnosis, treatment and prevention of STIs
• Anti-Retroviral Treatment
• Treatment of opportunistic infections
• Integration of TB and HIV diagnosis and treatment
What? (4)
Malaria priority areas for support

• Early diagnosis (microscopy or rapid tests) and treatment (artemesenin combination therapy)

• Preventive measures including
• Insecticide-treated bed nets
• Vector control, such as indoor residual spraying

• Surveillance and epidemic response
What? (5)
Tuberculosis priority areas for support I
Consolidation, maintenance & expansion of DOTS programme
• Improved case-finding
• Strengthened diagnostic capacity
• Quality control
• Drug supply
• Supervision & follow up of patients on treatment
What? (6)
Tuberculosis priority areas for support II

• Community education
• Awareness raising on illness
• Effective treatment-seeking behaviour
• Support to patients on treatment

• Development of public-private partnerships to expand DOTS

• Strengthening the monitoring of drug resistance

• Improved diagnosis & treatment of people co-infected with TB & HIV

When?
• First transfer of donor funds November 2006
• First Fund Board meeting November 2006

• December 2006 call for Expressions of Interest for additional interventions to support  prevention, care and treatment for those affected by the three diseases
    (deadline 22.01.07)
• April 2007 contracts to be finalised

• Two proposals approved to  support essential TB and malaria activities

• Fund Manager’s office to be established February 2007
    
How much?

- Around 90 million USD plus over 5 years

Thank you for your attention!